A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer

Clinical trial NCT06840548 · COMPLETED

Trial details

NCT number: NCT06840548
Sponsor: Philogen S.p.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma (ccRCC)

Start date: 2025-04-16
Primary completion: 2025-11-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.